Cargando…

Metabolic disease as a risk of hepatocellular carcinoma

Detalles Bibliográficos
Autor principal: Nishida, Naoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820215/
https://www.ncbi.nlm.nih.gov/pubmed/33317238
http://dx.doi.org/10.3350/cmh.2020.0302
_version_ 1783639161073303552
author Nishida, Naoshi
author_facet Nishida, Naoshi
author_sort Nishida, Naoshi
collection PubMed
description
format Online
Article
Text
id pubmed-7820215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-78202152021-01-27 Metabolic disease as a risk of hepatocellular carcinoma Nishida, Naoshi Clin Mol Hepatol Editorial The Korean Association for the Study of the Liver 2021-01 2020-12-03 /pmc/articles/PMC7820215/ /pubmed/33317238 http://dx.doi.org/10.3350/cmh.2020.0302 Text en Copyright © 2021 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Nishida, Naoshi
Metabolic disease as a risk of hepatocellular carcinoma
title Metabolic disease as a risk of hepatocellular carcinoma
title_full Metabolic disease as a risk of hepatocellular carcinoma
title_fullStr Metabolic disease as a risk of hepatocellular carcinoma
title_full_unstemmed Metabolic disease as a risk of hepatocellular carcinoma
title_short Metabolic disease as a risk of hepatocellular carcinoma
title_sort metabolic disease as a risk of hepatocellular carcinoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820215/
https://www.ncbi.nlm.nih.gov/pubmed/33317238
http://dx.doi.org/10.3350/cmh.2020.0302
work_keys_str_mv AT nishidanaoshi metabolicdiseaseasariskofhepatocellularcarcinoma